Due to the multitude and complexity of inherited<unk> s, the true prevalence is unknown; current data may be providing an underestimate. The prevalence of<unk>  in Caucasians is approximately 10-7,000 per 100,000 individuals worldwide. The prevalence of inherited<unk> s, specifically, activated protein C resistance and prothrombin G20210A , rises to approximately 10-60% in patients with documented venous thrombosis compared to less than 10% among patients without documented venous thrombosis.  The incidence of inherited<unk>  in incident venous thrombosis is approximately 150-840 per 100,000 person years. The incidence of inherited<unk>  in recurrent venous thrombosis is approximately 3,500-10,500 per 100,000 person-years.
Thrombophilia epidemiology and demographics
Von Willebrand disease epidemiology and demographics
High density lipoprotein epidemiology and demographics
Atherosclerosis epidemiology and demographics
Low density lipoprotein epidemiology and demographics
Deep vein thrombosis epidemiology and demographics
Hemophilia A epidemiology and demographics
Essential thrombocytosis epidemiology and demographics